JNJ vs HCA
By Alex · Tickerpine
Johnson & Johnson vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HCA |
|---|---|---|
| Price | $273.14 | $428.76 |
| Market cap | $658.24B | $92.83B |
| P/E ratio | 31.7 | 14.4 |
| ROE | 25.74% | — |
| Profit margin | 21.48% | 8.77% |
| Revenue growth | 6.60% | 8.70% |
| Dividend yield | 1.96% | 0.73% |
| Beta | 0.23 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HCA in plain English
- JNJ is the bigger company — about 7.1× the market cap of HCA.
- HCA is cheaper on earnings (P/E 14.4 vs 31.7).
- HCA is growing revenue faster (9% vs 7%).
- JNJ has the higher dividend yield (1.96% vs 0.73%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.